[In a view of international consensus conference for the treatment of H. pylori infection].
The first guideline of the treatment of H. pylori infection was reported by the working party of the World Congresses of Gastroenterology in 1990. Subsequently, many international consensus statements for the indication and the methods of eradication therapy for H. pylori infection were reported. And, now the standard regimens have been developed in European countries and U.S.A. The other hand, in Japan, the Ministry of Welfare has never been to approve the both of testing and treatment of H. pylori. One of the reasons is that there is a few scientific evidence for the benefit of the treatment of H. pylori infection in Japan. Since the resistant strains of H. pylori against antimicrobial agents are increasing in our country, we have to develop a strong and safety therapeutic regimen in Japan.
Watanabe
K
K
3rd Department of Internal Medicine, Kyorin University School of Medicine.
Takahashi
S
S
Saito
S
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D003226:Congresses as Topic; D004359:Drug Therapy, Combination; D005060:Europe; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori; D006801:Humans; D007564:Japan; D009853:Omeprazole / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors; D014481:United States
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors; D009853:Omeprazole